Reduced oxaliplatin exposure in gastrointestinal cancers: A systematic review and meta-analysis.
Wallace Klein Schwengber(WinnMed), Mohamad Bassam Sonbol(WinnMed), L F F Silva(Universidade Federal Fluminense), Fares Jamal(WinnMed), Ayla Kouli(WinnMed), Abdullah Alsulaiman(WinnMed), Oluseyi Abidoye(Mayo Clinic), Tanios S. Bekaii-Saab(WinnMed), Khalid Benkhadra(Mayo Clinic)
Cited by 0
Related Papers
Drugs Commonly Associated With Weight Change: A Systematic Review and Meta-analysis
|The Journal of Clinical Endocrinology & Metabolism|2015|328
ACTH Stimulation Tests for the Diagnosis of Adrenal Insufficiency: Systematic Review and Meta-Analysis
|The Journal of Clinical Endocrinology & Metabolism|2015|243
Circulating Tumor DNA Profiling of Advanced Biliary Tract Cancers
|JCO Precision Oncology|2019|86
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population
|European Journal of Cancer|2024|47